DNA vaccination is a promising immunization strategy that could be applied in the development of vaccines for a variety of prophylactic and therapeutic indications. Utilizing anthrax protective antigen as a model antigen, we demonstrate that electroporation mediated delivery enhanced the immunogenicity of DNA vaccines in nonhuman primates over 100-fold as compared to conventional intramuscular injection. Two administrations of a DNA vaccine with electroporation elicited anthrax toxin neutralizing antibody responses in 100% of rhesus macaques. Toxin neutralizing antibodies were sustained for the nearly 1-year study duration and were correlated with protection against subsequent lethal Bacillus anthracis spore challenge. Collectively, electroporation mediated DNA vaccination conferred protection comparable to that observed following vaccination with an FDA approved anthrax vaccine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2009.10.111 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.
Microorganisms
December 2024
Targeted Therapy Team, Institute for Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
The COVID-19 and mpox crisis has reminded the world of the potentially catastrophic consequences of biological agents. Aside from the natural risk, biological agents can also be weaponized or used for bioterrorism. Dissemination in a population or among livestock could be used to destabilize a nation by creating a climate of terror, by negatively impacting the economy and undermining institutions.
View Article and Find Full Text PDFToxin and capsule production by Bacillus cereus biovar anthracis influence pathogenicity in macrophages and animal models.
PLoS Negl Trop Dis
December 2024
Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Bacillus cereus biovar anthracis (Bcbva) causes anthrax-like disease in animals, particularly in the non-human primates and great apes of West and Central Africa. Genomic analyses revealed Bcbva as a member of the B. cereus species that carries two plasmids, pBCXO1 and pBCXO2, which have high sequence homology to the B.
View Article and Find Full Text PDFAre we ready for the next anthrax outbreak? Lessons from a simulation exercise in a rural-based district in Uganda.
Epidemiol Infect
December 2024
Department of Wildlife, Animal Resources Management, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.
Anthrax is a bacterial zoonotic disease caused by We qualitatively examined facilitators and barriers to responding to a potential anthrax outbreak using the capability, opportunity, motivation behaviour model (COM-B model) in the high-risk rural district of Namisindwa, in Eastern Uganda. We chose the COM-B model because it provides a systematic approach for selecting evidence-based techniques and approaches for promoting the behavioural prompt response to anthrax outbreaks. Unpacking these facilitators and barriers enables the leaders and community members to understand existing resources and gaps so that they can leverage them for future anthrax outbreaks.
View Article and Find Full Text PDFThe genome sequence of a non-capsular natural strain of A.Br.001/002 canSNP group isolated from permafrost in Yakutia, Russia.
Microbiol Resour Announc
November 2024
Laboratory of anthrax microbiology, State Research Center for Applied Microbiology and Biotechnology (SRCAMB), Obolensk, Russia.
We present the results of the whole-genome sequencing of a strain isolated from a permafrost sample collected in Yakutia, Russia. This strain was named YakM12. Phylogenetic analysis showed that YakM12 belongs to the canSNP group A.
View Article and Find Full Text PDFIdentification of molecular and cellular infection response biomarkers associated with anthrax infection through comparative analysis of gene expression data.
Comput Biol Med
January 2025
ICAR-National Institute of Veterinary Epidemiology and Disease Informatics, Bengaluru, Karnataka, 560064, India. Electronic address:
Bacillus anthracis, a gram-positive bacillus capable of forming spores, causes anthrax in mammals, including humans, and is recognized as a potential biological weapon agent. The diagnosis of anthrax is challenging due to variable symptoms resulting from exposure and infection severity. Despite the availability of a licensed vaccines, their limited long-term efficacy underscores the inadequacy of current human anthrax vaccines, highlighting the urgent need for next-generation alternatives.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!